Morie A. Gertz, MD
In a 20-year observational study, investigators at Mayo Clinic Rochester found that autologous stem-cell transplantation (ASCT) improved overall survival (OS) and reduced treatment-related mortality in patients with immunoglobulin light chain (AL) amyloidosis.
Sidiqi MH, Aljama MA, Buadi FK, et al. Stem cell transplantation for light chain amyloidosis: decreased early mortality over time [published online March 20, 2018]. J Clin Oncol. doi.org/10.1200/JCO.2017. 76.9554.
... to read the full story